20020 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Minocycline compounds for biodefense
#7502METHODS OF TREATING CANCER
#7503METHODS OF TREATING PHELAN MCDERMID SYNDROME USING FARNESYL DIBENZODIAZEPINONES
#7504Methods for increasing blood plasma 2′-deoxyuridine (dUrd) and thymidylate synthase inhibition
#7505Pharmaceutical compositions for subcutaneous administration of levosimendan
#7506THERAPEUTICS FOR PRETERM LABOR MANAGEMENT
#7507Benzo[b]thiophene STING agonists for cancer treatment
#7508Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
#7509High concentration medicant solutions for treating neurological disorders
#7510Process of Manufacturing a Stable, Ready to Use Infusion Bag for an Oxidation Sensitive Formulation
#7511INJECTABLE COMPOSITION COMPRISING HYALURONIDASE FOR REMOVING LOCAL FAT
#7512METHODS FOR THE TREATMENT OF CANCER USING COENZYME Q10 AND FATTY ACID METABOLISM INHIBITORS
#7513BIOCOMPATIBLE ORGANOGEL MATRICES FOR INTRAOPERATIVE PREPARATION OF A DRUG DELIVERY DEPOT
#7514Method for lyophilizing exosome
#7515CANCER BIOMARKERS AND METHODS OF USE
#7516Compositions and methods for treating retinal diseases
#7517Combination therapy of anti-CD20/anti-CD3 bispecific antibodies and 4-1BB (CD137) agonists
#7518Methods for modulating an immune response
#7519Thiophene compounds for long-acting injectable compositions and related methods
#7520Oxabicycloheptane prodrugs
#7521Treatment of osteoarthritis
#7522Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
#7523SOLID FORMS OF A PLASMA KALLIKREIN INHIBITOR AND SALTS THEREOF
#7524Pharmaceutical composition for the parenteral administration of ultrashort-effective β-adrenoreceptor antagonists
#7525Electrochemical plasma activated aqueous chemo therapeutics
#7526COMBINATION THERAPIES COMPRISING DENDRITIC CELLS-BASED VACCINE AND IMMUNE CHECKPOINT INHIBITOR
#7527MOLECULAR ENGINEERING OF A NOVEL TERNARY COMPLEX OF ACTINOMYCIN D FOR CANCER STEM CELLS TREATMENT
#7528METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#7529COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA
#7530Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease
#7531PHLIP®-MEDIATED TARGETING OF CORTICOSTEROIDS TO DISEASED TISSUE
#7532ANTIDIABETIC MEDICATIONS
#7533Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics
#7534NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
#7535Methods for inducing synaptogenesis with synaptic growth factor activating compounds
#7536Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
#7537Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient
#7538Modulation of gene expression in a human bioreactor
#7539DETERMINATION OF SMALL-MOLECULE THIOLS AND DISULFIDES: PROTEIN BOUND CYS AND TOTAL CYSTEINE AS BIOMARKERS OF OXIDATIVE STRESS
#7540Gene therapy for neurodegenerative disorders
#7541PH20 polypeptide variants, formulations and uses thereof
#7542PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK
#7543Method of administration of an anti-IFN-α/-ω antibody
#7544Compounds that modulate intracellular calcium
#7545Sodium thiosulfate-containing pharmaceutical compositions
#7546RADIOPHARMACEUTICALS AND METHODS OF USE THEREOF
#7547AAV CAPSID DESIGNS
#7548COMBINATIONS AND MODES OF ADMINISTRATION OF THERAPEUTIC AGENTS AND COMBINATION THERAPY
#7549LOCALLY ACTING TOLL-LIKE RECEPTOR 7 (TLR7) AND/OR TLR8 AGONIST IMMUNOTHERAPY COMPOUNDS AND THEIR USES
#7550PROPYLENE GLYCOL-CONTAINING PEPTIDE FORMULATIONS WHICH ARE OPTIMAL FOR PRODUCTION AND FOR USE IN INJECTION DEVICES
#7551Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors
#7552Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
#7553VACCINES AND METHODS OF VACCINATION AGAINST SCHISTOSOMA
#7554DNA VACCINES AND METHODS FOR THE PREVENTION OF TRANSPLANTATION REJECTION
#7555Compositions and methods for treatment of homocystinuria
#7556FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE
#7557DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS
#7558COLLAGEN 7 COMPOSITIONS AND METHODS OF USING THE SAME
#7559Tethered interleukin-2 to its receptor IL-2RBETA, a platform to enhance natural killer and regulatory T cell activity
#7560METHODS AND COMPOSITIONS FOR MITOCHONDRIAL REPLACEMENT THERAPY
#7561METHOD FOR BONE TISSUE REGENERATION IN EXPERIMENTS
#7562Methods and compositions for treating chlorine-gas induced lung injury
#7563Applications of triacetyl-3-hydroxyl phenyl adenosine in treating vascular inflammations or improving vascular endothelium functions
#7564DOSING REGIMEN FOR SEDATION WITH CNS 7056 (REMIMAZOLAM)
#7565Ganciclovir compositions and related methods
#7566Aripiprazole prodrug composition
#7567Methods of treating or preventing Zika virus infection
#7568PHARMACEUTICAL COMPOSITION COMPRISING CLEVIDIPINE AND PROCESS FOR PREPARATION THEREOF
#7569Compounds and compositions for inhibiting retinal pigment epithelium degeneration and methods using the same
#7570STABILIZED STATIN FORMULATIONS
#7571Dosing Regimen of Siponimod
#7572Parenteral treatments involving aminoadamantane derivatives
#7573Succinylcholine prefilled syringe, compositions and methods
#7574Gene therapies for lysosomal disorders
#7575RECOMBINANT URICASE ENZYME
#7576Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
#7577Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
#7578METHODS FOR CANCER TREATMENT USING A RADIOLABELED ANTI-CD45 IMMUNOGLOBULIN AND ADOPTIVE CELL THERAPIES
#7579ANTICANCER COMBINATION THERAPY
#7580Methods of treating AL amyloidosis
#7581Cartilage replacement compositions and methods
#7582DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY
#7583TRPV4 antagonist
#7584LXR inverse agonists for treatment of cancer
#7585Beta adrenergic agonist and methods of using the same
#7586Beta adrenergic agonist and methods of using the same
#7587Microporous annealed particle gels and methods of use
#7588Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals
#7589COMPOSITIONS AND METHODS FOR STABILIZING ALPHAVIRUSES WITH IMPROVED FORMULATIONS
#7590METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS
#7591COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID
#7592GHRH or analogues thereof for use in treatment of hepatic disease
#7593Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7594Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7595Polynucleotides Encoding Immunostimulatory Fusion Molecules and Uses Thereof
#7596Ferric maltol compositions for use in the treatment or prevention of cancer and tumours
#7597METHOD FOR TREATING ACUTE HYPOVOLEMIA
#7598Method and composition for preventing and treating viral infections
#7599COMPOUNDS AND METHODS OF THEIR USE
#7600WNT INHIBITORS FOR USE IN THE TREATMENT OF FIBROSIS
#7601Dosing Regimen of Siponimod
#7602INTRAVASCULAR DELIVERY OF NANOPARTICLE COMPOSITIONS AND USES THEREOF
#7603Composition for preparing an anti-tumour agent and a method for preparing an anti-tumour agent on the basis of same
#7604Microbial compositions and methods of use for improving milk production
#7605Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof
#7606RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES
#7607RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)
#7608Lyophilized formulations for factor Xa antidote
#7609LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
#7610CDKL5 EXPRESSION VARIANTS AND CDKL5 FUSION PROTEINS
#7611Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
#7612EGFR × CD28 multispecific antibodies
#7613Treatment of headache using anti-CGRP antibodies
#7614Gold(I) N-heterocyclic carbene thiourea complex and therapeutic compositions thereof
#7615Method of treating a proliferative disorder by administering a thiourea gold(I) complex
#7616Method of treating cancer and other proliferative diseases with a gold(I) complex
#7617Compounds, compositions, methods for treating diseases, and methods for preparing compounds
#7618Contrast agents for magnetic resonance imaging
#7619COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA
#7620SEQUENTIAL INTRAVITREAL ADMINISTRATION OF AAV GENE THERAPY TO CONTRALATERAL EYES
#7621HYDROGEL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF PEDIATRIC GROWTH PLATE INJURIES
#7622STABLE, AQUEOUS FORMULATIONS OF ANTIBODIES THAT BIND IL5 RECEPTOR
#7623STABILIZED PHARMACEUTICAL FORMULATIONS OF INSULIN ANALOGUES AND/OR INSULIN DERIVATIVES
#7624Pharmaceutical Composition For Treating Obesity Induced By High Fat Diet And Non-Alcoholic Fatty Liver Disease By Using Trisodium Chlorin E6 Photosensitizer
#7625Stabilized formulations containing anti-IL-33 antibodies
#7626Therapeutic SIRP-α antibodies
#7627Formulation of a peptide vaccine
#7628Use of botulinum neurotoxin in the treatment of sialorrhea
#7629Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#7630Targeted therapeutic lysosomal enzyme fusion proteins, associated formulations and uses thereof
#7631Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
#7632PHARMACEUTICAL COMPOSITIONS OF GHRH ANALOGS AND USES THEREOF
#7633Treating IgE-mediated allergic diseases
#7634TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION USING SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES
#7635COMBINATION METHOD FOR TREATMENT OF CANCER
#7636PREVENTIVE OR THERAPEUTIC AGENT FOR MUSCLE INJURY
#7637Nanoparticles conjugated with vasoactive intestinal peptide antagonists
#7638Mesenchymal stem cell derived exosomes and method for preventing or treating a joint disorder by administering a composition comprising the same
#7639COMPOSITIONS AND METHODS FOR REDUCING IMMUNE RESPONSES AGAINST CHIMERIC ANTIGEN RECEPTORS
#7640PHARMACEUTICAL COMPOSITION FOR TREATING JOINT INFLAMMATION
#7641Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
#7642Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof
#7643Prodrug salts
#7644Dosage regimen of paliperidone palmitate extended-release injectable suspension
#7645Methods of Treating Eye Disorders
#7646Apilimod compositions and methods for using same in the treatment of renal cancer
#7647P38 INHIBITORS FOR THE TREATMENT OF FSHD
#7648Methods of treating bacterial infections
#7649Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate
#7650IMMUNOTHERAPEUTIC AGENT
#7651Capsaicin Sequential Dosing Method for Treatment of Morton's Neuroma Pain
#7652Compositions and methods for treatment of cancer
#7653Composition and methods for stimulating clearance of amyloid-beta protein
#7654Extracellular redox enzyme system to alleviate disease
#7655Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indications
#7656POROUS MICROSPHERES INCLUDING MUSSEL ADHESIVE PROTEIN, AND METHOD FOR MANUFACTURING SAME
#7657Stable solutions of multicyclic antidepressants
#7658Methods for treating protozoan infections
#7659Inhibitors of microbially induced amyloid
#7660Methods and devices for localizing compositions
#7661TREATMENT OF CNS TUMORS
#7662Drug delivery system containing phospholipid and cholesterol
#7663Chikungunya virus RNA vaccines
#7664Zika virus RNA vaccines
#7665TOXOPLASMA GONDII VACCINES AND THEIR USE
#7666Nanovectors and uses
#7667TERIPARATIDE-CONTAINING LIQUID PHARMACEUTICAL COMPOSITION HAVING EXCELLENT PHARMACOKINETICS AND/OR SAFETY
#7668THERAPEUTIC AGENT PREPARATIONS AND METHODS FOR DRUG DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
#7669Methods and Compositions for the Inhibition of Quorum Sensing in Bacterial Infections
#7670CONDITIONING PROTOCOLS AND USE OF SAME FOR TISSUE REGENERATION
#7671Inhibiting or alleviating agent for Aβ-induced damage
#7672CHONDROCYTE PROLIFERATION
#7673TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY
#7674Tumor infiltrating lymphocytes and methods of therapy
#7675Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7676DETERMINISTIC MECHANOPORATION FOR CELL ENGINEERING
#7677Anti-CD19 antibodies
#7678Early apoptotic cells for use in treating sepsis
#7679Compositions and Methods for the Treatment of Metabolic Conditions
#7680Methods for treating chondrosarcoma using microrna(miR)
#7681Method of treating, reducing, or alleviating a medical condition in a patient
#7682Methods of treating certain depressive disorders and delirium tremens
#7683Testosterone ester triglyceride formulations
#7684Method for treating brain or nerve injury
#7685Aripiprazole formulations having increased injection speeds
#7686D-serine inhibit neuroinflammation due to a brain injury
#7687CYSTEINE COMPOSITION AND INJECTION
#7688CYSTEINE COMPOSITION AND INJECTION
#7689Cysteine composition and injection
#7690Method of Citric Acid as a Biochemical Enhancer
#7691Process of Manufacturing a Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
#7692Materials and methods for controlling infections
#7693Formulation for parenteral administration
#7694COMPOSITION WITH HIGH ANTIMICROBIAL ACTIVITY AND LOW TOXICITY
#7695GENE THERAPIES FOR NEURODEGENERATIVE DISEASES
#7696ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
#7697RNAi agents and compositions for inhibiting expression of Asialoglycoprotein receptor 1
#7698Methods and compositions for inhibiting expression of LDHA
#7699Compositions and Methods for Inhibiting Expression of Transthyretin
#7700COMPOSITIONS AND METHODS FOR MAKING AND USING BISPECIFIC ANTIBODIES
#7701Lipid-Based Antigens and T-Cell Receptors on NK Cells
#7702CD44V6-DERIVED CYCLIC PEPTIDES FOR TREATING CANCERS AND ANGIOGENESIS RELATED DISEASES
#7703PHARMACEUTICALS AND DEVICES FOR THE COVALENT IMMOBILIZATION TO THE EXTRACELLULAR MATRIX BY TRANSGLUTAMINASE
#7704Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
#7705Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid
#7706PSMA targeted fluorescent agents for image guided surgery
#7707Apoptosis signal-regulating kinase inhibitors and uses thereof
#7708Gene therapies for lysosomal disorders
#7709GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)
#7710Amphiphilic dye-coated inorganic nanoparticle clusters
#7711STABILIZING EXCIPIENTS FOR THERAPEUTIC PROTEIN FORMULATIONS
#7712FORMULATIONS OF BENDAMUSTINE
#7713Anti-IL-36R antibody formulations
#7714EPSTEIN-BARR VIRUS VACCINES
#7715Compositions and methods for generating an immune response to treat or prevent malaria
#7716METHODS AND COMPOSITIONS FOR REDUCING LUNG INJURY ASSOCIATED WITH LUNG TRANSPLANTATION
#7717METHODS FOR TREATING OSTEOARTHRITIS PAIN
#7718SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF
#7719GLP-1 FUSION PROTEINS AND USES THEREOF
#7720Method of Treating Myasthenia Gravis
#7721Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth
#7722Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy
#7723Method for treating cancer
#7724Treatment of immune disorders
#7725PRODUCTS AND METHODS USING A PLATELET-DERIVED HEMOSTATIC AGENT FOR CONTROLLING BLEEDING AND IMPROVING HEALING
#7726Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7727METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#7728Abiraterone prodrugs
#7729MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE
#7730Microspherical sustained-release injection containing escitalopram and method for preparing same
#7731Compositions and methods for diagnosing and treating peroxisomal diseases
#7732LIGANDS BINDING TO PRION PROTEIN FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES
#7733PHARMACEUTICAL COMPOSITION COMBINING IMMUNOLOGIC AND CHEMOTHERAPEUTIC METHOD FOR THE TREATMENT OF CANCER
#7734TREATMENT OF OCULAR DISEASES WITH FULLY-HUMAN POST-TRANSLATIONALLY MODIFIED ANTI-VEGF Fab
#7735VIRAL FUSION PROTEIN TREATMENT FOR CCR8 MEDIATED DISEASES
#7736Modulators of melanocortin receptors for the treatment of depression and anxiety
#7737Iron compositions and methods of making and using the same
#7738Radiolabeled Darapladib and analogs thereof and their use as imaging compounds
#7739Gene therapies for lysosomal disorders
#7740New Therapy for Pompe Disease
#7741Pharmaceutical Formulations
#7742Immunogenic composition for the treatment of cancer
#7743A METHOD TO CREATE PERSONALIZED CANCER VACCINES
#7744Methods of using C1 esterase inhibitor for improving early onset and long-term function of kidney transplants from grafts associated with delayed graft function
#7745Compositions and methods for treatment of homocystinuria
#7746Treatment of inflammatory skin disorders
#7747PTH Prodrugs
#7748Therapies for Obesity, Diabetes and Related Indications
#7749METHOD FOR TREATING MYELOID LEUKEMIA
#7750Treatment of post-bariatric hypoglycemia with GLP-1 antagonists
#7751Treatment of post-bariatric hypoglycemia with exendin (9-39)
#7752Use of recombinant protein for treating metabolic disorders
#7753Method for treating allergic airways disease (AAD)/asthma
#7754Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7755Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
#7756Regulatory macrophages for treating angiopathies
#7757Use of composition comprising stem cell-derived exosome as effective ingredient in strengthening skin barrier and improving skin barrier function
#7758PARTICLES FOR THE TREATMENT OF CANCER IN COMBINATION WITH RADIOTHERAPY
#7759IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#7760IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES
#7761METHODS FOR TREATING CUTANEOUS T-CELL LYMPHOMA (CTCL) WITH MIR-155 INHIBITORS
#7762METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS
#7763COMBINATION THERAPY FOR IMMUNOLOGICAL DISEASES
#7764METHODS USING 3-(4-AMINO-1-OXO-1,3-DIHYDRO-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE FOR TREATMENT OF INTERMEDIATE LYMPHOCYTIC LYMPHOMA
#7765CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLINES FOR TREATMENT OF CANCER
#7766METHODS OF TREATING NEUROLOGICAL DISORDERS
#7767PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS
#7768Antidotes to cyanide poisoning
#7769Dosage forms and related therapies
#7770Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#7771Pharmaceutical compositions for intraarticular delivery
#7772Hydrogel toxin-absorbing or binding nanoparticles
#7773Systems and methods for enhanced distribution of a biologic agent within the brain and spinal cord
#7774Dipivefrin orally disintegrating tablet formulations
#7775Cancer-specific trans-splicing ribozymes and use thereof
#7776Beta catenin nucleic acid inhibitor molecule
#7777P97-IDS fusion proteins
#7778Means and methods for treating and diagnosing fibrosis or fibrosis-associated diseases
#7779MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF
#7780Cancer treatment drug
#7781SRPK1 inhibitors
#7782Syringe Holder
#7783IN-SITU GEL-FORMING DELIVERY SYSTEMS, METHODS AND COMPOSITIONS
#7784Pharmaceutical compositions having improved storage stability
#7785Cancer treatments
#7786Treatment of severe community acquired pneumonia
#7787Methods and compositions for treating hunter syndrome
#7788Methods of Treating Newly Diagnosed Multiple Myeloma with a Combination of An Antibody that Specifically Binds CD38, Lenalidomide and Dexamethasone
#7789NORRIN INDUCED EXPRESSION OF GENES AND USE THEREOF TO TREAT DISEASE
#7790Compounds For Use in NASH
#7791Compositions and methods for the treatment of fungal infections
#7792Therapeutic compositions
#7793Biochemical and biomechanical conditioning for enhancing personalized mesenchymal stem cell therapies
#7794Nucleic acid molecule with anti-inflammatory and anti-coagulant and organ-protective properties
#7795COMBINATION THERAPY FOR CANCER
#7796Methods for treating pulmonary non-tuberculous mycobacterial infections
#7797Emulsion composition for chemoembolization and method for producing same
#7798Medical methods utilising high purity diaminophenothiazinium compounds
#7799Apilimod compositions and methods for using same
#7800Combination Therapy for Cancer Treatment